HUMAN DERMAL MESENCHYMAL STEM CELLS AS NANOPARTICLES VEHICLES

Alėja Marija Daugėlaitė1, 2, Greta Jarockytė1, 2, Artiom Skripka3, Vilius Poderys1, Vitalijus Karabanovas1, 4, Fiorenzo Vetrone3, Ričardas Rotomskis1, 5

1 Biomedical Physics Laboratory of National Cancer Institute, Vilnius, Lithuania

2 Life Sciences Center, Vilnius University, Vilnius, Lithuania

3 Centre Énergie, Matériaux et Télécommunications, Institut National de la Recherche Scientifique, Université du Québec, Varennes, QC, Canada

4 Department of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Vilnius, Lithuania

5 Biophotonics group of Laser Research Centre, Vilnius University, Vilnius, Lithuania

Oncological diseases remain a major problem worldwide. There is still no effective method for detecting cancer at an early stage, and the treatments currently on the market are non-specific and cause side effects. One solution is to use mesenchymal stem cells (MSCs) in combination with upconverting nanoparticles (UCNPs). UCNPs are small in size, have low toxicity and, due to their photoluminescent properties, could be used as fluorophores in cancer diagnostics and treatment [1]. However, only a small fraction of nanoparticles reaches cancer cells due to their low specificity and microenvironmental effects. MSCs have great potential in the field of medicine due to their regenerative properties, their anti-tumour efficacy and their migration towards inflammation and cancer due to chemokine stimulation. Because of these MSCs properties, they could be used as "Trojan horses" to deliver nanoparticles directly to the tumour. Therefore, combining stem cells with UCNPs could lead to an innovative approach to cancer theranostics – therapy combined with diagnostics [2].

The aim of the study was to investigate the in vitro properties and theranostic potential of upconverting nanoparticles and mesenchymal stem cells. In our study, we investigated upconverting nanoparticles with an embedded photosensitizer chlorin e6 (Ce6) (UCNPs-Ce6). Along with that, we used chlorine-free UCNPs as controls. Different excitation wavelengths produce different effects – 980 nm excitation produces a therapeutic effect, while 793 nm excitation produces photoluminescence in the near-infrared part of the spectrum, which is suitable for diagnostics. The irradiation used to excite the UCNPs ($\lambda_{ex}$ = 980 nm and $\lambda_{ex}$ = 793 nm) falls within the optical tissue transparency window (650-1300 nm). This light is more penetrating in biological tissues, allowing it to reach deeper tissues without damaging them.

Intracellular accumulation of upconverting nanoparticles in MSCs and human breast cancer cell lines MCF-7, MDA-MB-231 was demonstrated using confocal microscopy. In addition, the cytotoxicity of the nanoparticles was assessed using the lactate dehydrogenase (LDH) cytotoxicity test. A wound healing assay was also used to demonstrate MSCs migration after incubation with UCNPs. Finally, the potential efficacy of photodynamic effect of UCNPs-Ce6 was investigated. After irradiation with 980 nm laser light, the cells were stained with the fluorescent viability dyes calcein AM and propidium iodide.

Our results demonstrated that UCNPs and UCNPs-Ce6 accumulate inside MSC, MCF-7, MDA-MB-231 cells and localize in endocytic vesicles, especially around the nucleus. This pattern of nanoparticles accumulation in cells is common for all endocytic pathways, including UCNPs [1]. Moreover, we showed that both UCNPs and UCNPs-Ce6 are non-toxic for MSC, MCF-7, MDA-MB-231 cells when cells are incubated with nanoparticles in the dark for up to 24 h. A wound healing assay demonstrated that intracellular accumulation of UCNPs does not affect the migration of MSCs towards the scratch. Additionally, our results showed that UCNPs-Ce6 accumulated in cells and irradiated with 980 nm laser excitation has a significant phototoxic effect on cells, while UCNPs alone are non-toxic.

Overall, MSCs combined with upconverting nanoparticles show great potential in cancer theranostics.


[1] E. Voronovic, A. Skripka, G. Jarockyte, et al., Uptake of Upconverting Nanoparticles by Breast Cancer Cells: Surface Coating versus the Protein Corona, ACS Appl. Mater. Interfaces 13, 39076-39087 (2021).

[2] D. Dapkute, M. Pleckaitis, D. Bulotiene, et al., Hitchhiking Nanoparticles: Mesenchymal Stem Cell-Mediated Delivery of Theranostic Nanoparticles, ACS Appl. Mater. Interfaces 13, 43937-43951 (2021).